The U.S. Department of Health and Human Services (HHS) has awarded a joint $90 million, five-year agreement to CITI, the software services and product company, and C3 AI (NYSE: AI), the Enterprise AI application software company, through its partnership with Carahsoft.
The Blanket Purchase Agreement (BPA), called “Solutioning with Holistic Analytics Restructured for the Enterprise (SHARE),” will accelerate enterprise AI deployments across the entire HHS, which includes the National Institutes of Health (NIH), the Food and Drug Administration (FDA), and the Centers for Disease Control and Prevention (CDC).
Through the SHARE BPA, the HHS’s various agencies and missions can select C3 AI to support data-driven work. For example, the HHS can leverage the C3 AI Application Platform to rapidly deploy use cases and scale AI applications to solve public health challenges in the event of a future pandemic. The BPA allows HHS officials to procure CITI services, C3 AI applications, and C3 AI’s secure and powerful AI platform for data collection, analysis with machine learning, and predictive AI capabilities.
“Our public health agencies, including the FDA and CDC, are under incredible pressure to solve complex, life-threatening problems, ranging from supply chain optimization for baby formula to understanding and thwarting the next global pandemic. These problems cannot be solved without machine learning and enterprise AI capabilities,” said Thomas M. Siebel, Chairman and CEO of C3 AI. “We are proud to deliver the world’s leading AI technologies, people, and partners to HHS, and we look forward to supporting the department’s vital missions.”
“I am very pleased to partner with C3 AI and provide agile development services to HHS agencies to integrate the C3 AI platform via this new SHARE BPA,” said Sunil Kolhekar, President and CEO of CITI… Read the full release here.